pH (low) insertion peptide (pHLIP) targets ischemic myocardium.

Eugene A Sosunov1, Evgeny P Anyukhovsky, Alexander A Sosunov

  • 1Department of Pharmacology, Columbia University, New York, NY 10032, USA.

Summary

pH (low) insertion peptide (pHLIP) targets ischemic myocardium, offering a new diagnostic and therapeutic approach. This pH-sensitive peptide binds to affected heart tissue without causing damage, enabling targeted drug delivery.